Literature DB >> 30847866

How Important it is to Differentiate AMAN from AIDP in Childhood GBS? A Clinician's Perspective.

Juhi Gupta1, Prashant Jauhari2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30847866     DOI： 10.1007/s12098-019-02918-3

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  6 in total

1.  Childhood Guillain-Barré syndrome subtypes in northern India.

Authors:  Naveen Sankhyan; Suvasini Sharma; Ramesh Konanki; Sheffali Gulati
Journal:  J Clin Neurosci       Date:  2013-10-13       Impact factor: 1.961

2.  How Different is AMAN from AIDP in Childhood GBS? A Prospective Study from North India.

Authors:  Pradeep Kumar Gupta; Pratibha Singhi; Sunit Singhi; Ananthanarayanan Kasinathan; Naveen Sankhyan
Journal:  Indian J Pediatr       Date:  2019-01-12       Impact factor: 1.967

3.  Prospective comparison of acute motor axonal neuropathy and acute inflammatory demyelinating polyradiculoneuropathy in 140 children with Guillain-Barré syndrome in India.

Authors:  Jayantee Kalita; Mritunjai Kumar; Usha K Misra
Journal:  Muscle Nerve       Date:  2017-11-07       Impact factor: 3.217

Review 4.  Axonal Guillain-Barré syndrome: concepts and controversies.

Authors:  Satoshi Kuwabara; Nobuhiro Yuki
Journal:  Lancet Neurol       Date:  2013-12       Impact factor: 44.182

5.  Factors predicting poor outcome in patients with fulminant Guillaine-Barré syndrome.

Authors:  Nandagopal Nithyashree; Madhuram Dhanaraj; Senthil Kumar; M B Saraswathi
Journal:  Ann Indian Acad Neurol       Date:  2014-10       Impact factor: 1.383

6.  Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain-Barre Syndrome: Is Single Dose Adequate?

Authors:  Priyanka Madaan; Prashant Jauhari; N M Shruthi; Biswaroop Chakrabarty; Sheffali Gulati
Journal:  Ann Indian Acad Neurol       Date:  2019 Jan-Mar       Impact factor: 1.383
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.